JL Malo, A Cartier, J Cote, J Milot, C Leblanc, L Paquette, H Ghezzo and LP Boulet
Department of Chest Medicine, Hopital du Sacre-Coeur, Montreal Canada.

Occupational asthma (OA) is a useful model for the study of asthma in humans. The possibility that inhaled corticosteroids, in addition to withdrawal from the workplace, could improve clinical and functional recovery from OA can be hypothesized. We assessed clinical, functional, and behavioral characteristics of 32 subjects (22 male, 10 female), in all but one of whom OA was confirmed by specific inhalation challenges induced by either high- (n=13) or low-molecular-weight (n=19) agents within 3 mo after cessation of exposure. In this randomized, crossover, double-blind study, subjects (paired for baseline PC20 and duration of symptoms after exposure) received either placebo or 1,000 micrograms of inhaled beclomethasone daily for 1 yr, followed by the alternate medication for 6 mo. Various clinical, functional, and behavioral parameters were examined at each 3-mo visit. Significant improvement in clinical (nocturnal symptoms, cough), functional (morning and evening peak expiratory flow rates), and behavioral (quality of life) parameters were detected in the active-treatment period, although the magnitude of the improvement was relatively small. Side effects (oropharyngeal, reduced cortisol) were similar in the placebo and treatment groups. Distinguishing subjects who started with the active preparation from those who were given placebo first showed that most clinical and behavioral parameters improved in the former instance, whereas there was no significant difference in the latter. We conclude that inhaled corticosteroids induce a small but significant overall improvement of the asthmatic condition in subjects with occupational asthma caused by high- and low-molecular-weight agents after withdrawal from exposure. The beneficial effect is, however, more pronounced if inhaled steroids are given early after diagnosis.

This article has been cited by other articles:

				S. M. Tarlo, J. Balmes, R. Balkissoon, J. Beach, W. Beckett, D. Bernstein, P. D. Blanc, S. M. Brooks, C. T. Cowl, F. Daroowalla, et al. Diagnosis and Management of Work-Related Asthma: American College of Chest Physicians Consensus Statement Chest, September 1, 2008; 134(3_suppl): 1S - 41S. [Abstract] [Full Text] [PDF]

				G. Rachiotis, R. Savani, A. Brant, S. J MacNeill, A. Newman Taylor, and P. Cullinan Outcome of occupational asthma after cessation of exposure: a systematic review Thorax, February 1, 2007; 62(2): 147 - 152. [Abstract] [Full Text] [PDF]

				M Abramson and M R Sim Occupational asthma Thorax, September 1, 2006; 61(9): 741 - 742. [Full Text] [PDF]

				J.-L. Malo Future advances in work-related asthma and the impact on occupational health Occup. Med., December 1, 2005; 55(8): 606 - 611. [Abstract] [Full Text] [PDF]

				C. E. Mapp, P. Boschetto, P. Maestrelli, and L. M. Fabbri Occupational Asthma Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 280 - 305. [Abstract] [Full Text] [PDF]

				J.-L. Malo and H. Ghezzo Recovery of Methacholine Responsiveness after End of Exposure in Occupational Asthma Am. J. Respir. Crit. Care Med., June 15, 2004; 169(12): 1304 - 1307. [Abstract] [Full Text] [PDF]

				O. Vandenplas, K. Toren, and P.D. Blanc Health and socioeconomic impact of work-related asthma Eur. Respir. J., October 1, 2003; 22(4): 689 - 697. [Abstract] [Full Text] [PDF]

				Proceedings of the First Jack Pepys Occupational Asthma Symposium Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 450 - 471. [Full Text] [PDF]

				L.-P. BOULET, H. TURCOTTE, M. LAVIOLETTE, F. NAUD, M.-C. BERNIER, S. MARTEL, and J. CHAKIR Airway Hyperresponsiveness, Inflammation, and Subepithelial Collagen Deposition in Recently Diagnosed versus Long-standing Mild Asthma . Influence of Inhaled Corticosteroids Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1308 - 1313. [Abstract] [Full Text] [PDF]